InformedDNA
PrivateLast Round
Debt
Feb 27, 2020
Total Funding Raised
$10M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
InformedDNA operates in Healthcare & Life Sciences and is based in St. Petersburg, Florida. Its latest recorded funding round was a Debt round in February 2020.
InformedDNA is a healthcare technology company that provides genetic counseling, genetic testing utilization management, and precision health solutions to payors, providers, and patients.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Telemedicine, Clinical Trials, Healthcare Analytics, Compliance & Risk
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
InformedDNA Comparables
Compare InformedDNA with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Genome Medical | 90% | |
| My Gene Counsel | 81% | |
| DNAvisit | 78% |
For institutional investors. Book with your work email.
InformedDNA Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Feb 27, 2020 | ||||
| Growth Equity | Dec 23, 2019 | ||||
| VC Round | Jul 31, 2014 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
InformedDNA Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Zaffre Investments | VC Round |
| Frist Cressey Ventures | Growth Equity |
| CIBC Innovation Banking | Debt |
| NovaQuest Capital Management | Growth Equity |
| Truehelm | Growth Equity |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 65% MoM, reaching 7K.
- Jun 2, 2025
Monthly visitors increased 136% MoM, reaching 6.6K.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- launchesOct 9, 2026
InformedDNA is soon launching a patient-centric precision health platform as part of its strategy to become the first Genomic Digital Health company.
- sells_assets_toAug 31, 2026
InformedDNA completes the sale of its Genetic Testing Utilization Management business, which advises health plans on the clinical suitability of genetic tests, to Zyter in Maryland on Aug 31st '26; no deal value is disclosed.
For institutional investors. Book with your work email.
InformedDNA Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about InformedDNA's valuation, stock price, and market status.
Is InformedDNA a public or private company?
InformedDNA is a private company.
What is the current stock price of InformedDNA?
InformedDNA is a private company, so its shares have no public market price. Caplight tracks InformedDNA's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is InformedDNA worth (valuation)?
Valuation information for InformedDNA is not publicly available.
Can I buy InformedDNA stock?
InformedDNA shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was InformedDNA's last funding round?
InformedDNA's most recent funding round was Debt on February 27, 2020.
Who are the main investors in InformedDNA?
Key investors in InformedDNA include Zaffre Investments, CIBC Innovation Banking.
Will InformedDNA IPO soon?
No public IPO plans have been announced for InformedDNA.
How can I track InformedDNA secondary market activity?
Caplight tracks bids, offers, and trades in InformedDNA's shares on secondary markets.